ArticleAnnals of surgical oncology2024

Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.

Julia Tchou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.